OP Asset Management
VIR icon

OP Asset Management’s Vir Biotechnology VIR Stock Holding History

OP Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.39M Sell
123,904
-28,353
-19% -$284K 0.01% 539
2026
Q2 		$1.55M Buy
152,257
+39,229
+35% +$373K 0.02% 532
2026
Q1 		$1.01M Buy
+113,028
New +$901K 0.01% 602

Other funds holding VIR

GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Savvy Advisors Inc
Savvy Advisors Inc New York $6.03B AUM 17.97% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

OP Asset Management's VIR Position: Q3 2026 in Review

OP Asset Management reduced its Vir Biotechnology (VIR) stake by 19% in Q3 2026, selling an estimated $284K and leaving 123,904 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #539.

OP Asset Management first reported a position in VIR in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.55M in Q2 2026. 167 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • OP Asset Management held 123,904 shares of Vir Biotechnology worth $1.39M as of Q3 2026.
  • OP Asset Management sold 28,353 Vir Biotechnology shares in Q3 2026, an estimated $284K.
  • Vir Biotechnology made up 0.01% of OP Asset Management's portfolio in Q3 2026, its #539 holding.
  • OP Asset Management first reported a position in Vir Biotechnology in Q1 2026 and has held it in 3 quarters since.
  • OP Asset Management's Vir Biotechnology position peaked at $1.55M in Q2 2026.
  • 167 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on OP Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.